US2019194687A1PendingUtilityA1

Efficient non-meiotic allele introgression in livestock

Individually held — no corporate assignee on recordPriority: Aug 27, 2013Filed: Mar 6, 2019Published: Jun 27, 2019
Est. expiryAug 27, 2033(~7.1 yrs left)· nominal 20-yr term from priority
C12N 2800/90C12N 2800/30C12N 15/907C12N 15/8771C12N 15/8778C12N 2750/14143A01K 67/0275C07K 14/715C07K 14/47C12N 15/8509C12N 15/85
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods, uses, and animals for introgression of alleles between animals, including SNPs. One embodiment involves introducing a targeted targeting endonuclease system and a HDR template into a cell with a mismatch in the binding of the targeting endonuclease and the targeted site.

Claims

exact text as granted — not AI-modified
1 . A method of modifying a bovine cell, the method comprising:
 contacting the bovine cell with a targeted endonuclease that targets and cuts a gene encoding the prolactin receptor;   contacting the bovine cell with a homology-dependent repair template such that the template integrates into the genome of the bovine cell to encode a truncated prolactin receptor protein.   
     
     
         2 . The method of  claim 1 , wherein the truncated prolactin receptor protein is 461 amino acids in length. 
     
     
         3 . The method of  claim 1 , wherein the targeted endonuclease is selected from a zinc finger nuclease, a TAL effector nuclease (TALEN), and a CRISPR/Cas 9 nuclease. 
     
     
         4 . The method of  claim 3 , wherein the targeted endonuclease is a TAL effector nuclease (TALEN). 
     
     
         5 . The method of  claim 4 , wherein the TALEN has zero mismatches to a targeted region of the gene encoding the prolactin receptor. 
     
     
         6 . The method of  claim 1 , wherein contacting the bovine cell with a targeted endonuclease comprises expressing exogenous mRNA encoding a TAL effector nuclease (TALEN).

Join the waitlist — get patent alerts

Track US2019194687A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.